Cite
Christodoulou I, Ho WJ, Marple A, et al. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. J Immunother Cancer. 2021;9(12)doi: 10.1136/jitc-2021-003894.
Christodoulou, I., Ho, W. J., Marple, A., Ravich, J. W., Tam, A., Rahnama, R., Fearnow, A., Rietberg, C., Yanik, S., Solomou, E. E., Varadhan, R., Koldobskiy, M. A., & Bonifant, C. L. (2021). Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. Journal for immunotherapy of cancer, 9(12), . https://doi.org/10.1136/jitc-2021-003894
Christodoulou, Ilias, et al. "Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities." Journal for immunotherapy of cancer vol. 9,12 (2021). doi: https://doi.org/10.1136/jitc-2021-003894
Christodoulou I, Ho WJ, Marple A, Ravich JW, Tam A, Rahnama R, Fearnow A, Rietberg C, Yanik S, Solomou EE, Varadhan R, Koldobskiy MA, Bonifant CL. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities. J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003894. PMID: 34896980.
Copy
Download .nbib